Clinical trial
A Post-Market Clinical Follow-up Study to Evaluate the Long-Term Safety and Effectiveness of Surpass Evolve Flow Diverter System
NCT06368622 is registered in ClinicalTrials.gov with Stryker Neurovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Post-Market Clinical Follow-up Study to Evaluate the Long-Term Safety and Effectiveness of Surpass Evolve Flow Diverter System
- Lead sponsor
- Stryker Neurovascular
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- April 24, 2024
- Completion date
- August 31, 2031
- Enrollment
- 500 (estimated)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.